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contralateral breast, humeral head, spinal cord, skin and ipsolateral lung). We also compared the uniformity and the van’t Riet
conformation indexes.
Results. Comparing the techniques by pairs, the results indicated that the segmented technique is superior to classical for breast-
only cases, specially for left breasts due to heart sparing. No signiﬁcances were observed for chest wall and lymph nodes cases
except better avoidance of OAR dose for segmented. IMRT is statistically better than classical for all kind of cases, though it carries
more low doses for OAR. Finally, IMRT is superior to segmented for breast-only and lymph nodes cases, but they are statistically
equiparable for chest walls. Again IMRT supposes more low doses for OAR.
Conclusion. This pilot study has given us a better understanding of the capabilities of every technique and helped us decide the
most appropriate dosimetric planning protocol for every breast case.
http://dx.doi.org/10.1016/j.rpor.2013.03.082
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Introduction. The management of information is crucial to optimize the operation of Breast Functional Units and ensure the
success of personalized medicine.
Objective. To have an advanced tool that allows the “integration of all the information generated by the services” involved in Breast
Functional Units, including the service of Radiation Oncology. Providing professionals a support system for clinical decision
helping them to decide what to do with the patient, during diagnosis, prognosis and treatment of the disease and enabling
personalized healthcare.
Material and methods. Task groups with all specialties, analyzing their structure, protocols, records and workﬂow between profes-
sionals, obtaining a collection of requirements to implement in the new information system. Prototypes are developed to validate
the interfaces, functionality and usability of the ﬁnal product, ensuring alignment with existing coding standards, procedures
and health information technology.
Results. Platform “patient-oriented” to improve the effectiveness of exchange of information and knowledge between profession-
als, offering a centralized view of the disease in real time and support tools for decision based in semantics. The obtained tool
is aligned with the following elements: • Electronic medical records; • Conﬁdentiality; • Collaborative work between different
services; • Support for professionals (ontologies to propose and guide in clinical decision); • Improving the quality of information
handled and the time spent in the query.
Conclusions. The new platform will provide to the professionals of the services involved in the diagnosis and treatment of breast
cancer, a new way of working, based on information technologies. Semantic ontologies have been implemented oriented to the
healthcare environment in the areas of diagnosis, individualized treatment and clinical decision support.
http://dx.doi.org/10.1016/j.rpor.2013.03.083
Concomitant boost in early breast cancer
R. del Moral, I. Tovar, M. Zurita, P. Vargas, R. Guerrero, M. Gentil, I. Linares, M. Martínez, M. Navarro
Hospital Universitario Virgen de Las Nieves, Oncología Radioterápica, Spain
Introduction. Breast-conserving therapy is the standard of care for early breast cancer. The conventional technique of radiotherapy
includes irradiation to the whole breast followed by a tumour bed boost. Reducing the overall treatment time could decrease the
inconvenience to the patient.
Objective. To evaluate toxicity, cosmetic result and survival in patients with breast cancer treated with radiotherapy and con-
comitant boost to the tumour bed in our centre between 2007 and 2009.
Methods. Descriptive and retrospective analysis. All patientswere treatedwith 3D-conformal external radiotherapy. They received
50Gy to the whole breast, 2Gy per fraction, 5 fractions per week. Toxicities were scored according to the common toxicity criteria
version 4.
Results. 196 patients underwent radiotherapy with concomitant boost between September of 2008 and April of 2010. We collected
data from 162 patients. Median follow-up was 30 months. Median age 52 years, the majority of cases were: postmenopausal
women (54%), ductal histology (75.3%), hormone receptor-positive (81%), HER-2-negative (79%), stage I-IIA (72%). Patients under-
went tumorectomy in 91% and axillar surgery in 73.5%. In 39 patients boost daily doses was 0.53Gy and 0.34Gy in 123 women.
The most common acute toxicity was radiodermitis grade 1 (49.4%) and ﬁbrosis grade 1–2 was the most frequent late toxicity.
